RCD advises AlbaJuna Therapeutics, an IrsiCaixa spin-off, on the inflow of capital that will fund the development of antibodies against HIV

by RCD

RCD – Rousaud Costas Duran has advised AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, on the investment of €3.75M by the pharmaceutical company Grifols, which will s...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Comienza la edición 88 de programa de a...

by mentorDay

En esta edición contamos con emprendedores de África, Latinoamérica...

Photos Stream